o Estee Lauder Companies, Inc.’s (NYSE:EL) second quarter 2012 quarterly earnings increased 17% year over year to $1.00 per share, but missed the Zacks Consensus Estimate of $1.01 by a penny
o After concerns arose that Idenix Pharmaceuticals, Inc.’s (Nasdaq:IDIX) hepatitis C drug would be unable to compete with Gilead Sciences, Inc. (Nasdaq:GILD) drug, shares of Idenix declined by 11.5%
o Genworth Financial Inc’s (NYSE:GNW) fourth quarter operating income came in at $0.17 per share, in line with the Zacks Consensus Estimate
o Sony Corporation (NYSE:SNE) reported that it has laid off 100 employees over the past few weeks
To read this article on Zacks.com click here.
Zacks Investment Research
